Table 4.
Effect sizes for the pre-post treatment effects of VR exposure therapy and in vivo exposure therapy.
Pre | Post | Effect size | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
95% CI | ||||||||||||
References | Phobia | Sample | Anxiety measure | n | M | SD | M | SD | g | LL | UL | |
Rothbaum et al., 2000 | Specific Phobia | Completer | FFI | VRET | 15 | 105.85 | 35.91 | 86.14 | 37.40 | 0.51 | −0.22 | 1.23 |
(fear of flying) | IVET | 15 | 133.30 | 42.00 | 87.53 | 42.30 | 1.03 | 0.17 | 1.88 | |||
Emmelkamp et al., 2002 | Specific Phobia | Completer | AQ-Anxiety | VRET | 17 | 57.12 | 12.18 | 36.12 | 20.56 | 1.18 | 0.33 | 2.04 |
(fear of heights) | IVET | 16 | 59.06 | 17.12 | 42.19 | 17.14 | 0.93 | 0.13 | 1.74 | |||
Rothbaum et al., 2006 | Specific Phobia | ITT | FFI | VRET | 29 | 120.38 | 44.24 | 103.69 | 49.35 | 0.35 | −0.17 | 0.86 |
(fear of flying) | IVET | 29 | 116.79 | 57.74 | 100.34 | 43.49 | 0.31 | −0.20 | 0.83 | |||
Michaliszyn et al., 2010 | Specific Phobia (fear of spiders) | Completera, b | FSQ | VRET | 16 | 104.61 | 9.59 | 54.37 | 22.46 | 2.76 | 1.26 | 4.27 |
IVET | 16 | 103.28 | 13.13 | 47.88 | 14.07 | 3.86 | 1.86 | 5.87 | ||||
Anderson et al., 2013 | Social Phobia | ITT | PRCS | VRET | 30 | 24.37 | 2.54 | 16.23 | 7.61 | 1.40 | 0.70 | 2.10 |
IVET | 39 | 25.59 | 2.59 | 14.79 | 8.53 | 1.68 | 1.00 | 2.36 | ||||
Kampmann et al., 2016 | Social Phobia | ITTa | LSAS-SR | VRET | 20 | 73.00 | 17.25 | 55.74 | 18.65 | 0.92 | 0.20 | 1.64 |
IVET | 20 | 69.15 | 19.44 | 39.22 | 25.01 | 1.28 | 0.46 | 2.10 | ||||
Bouchard et al., 2016 | Social Phobia | ITT | LSAS-SR | VRET | 17 | 85.1 | 29.5 | 51.8 | 23.3 | 1.19 | 0.34 | 2.05 |
IVET | 22 | 74.9 | 24.5 | 56.0 | 26.9 | 0.71 | 0.07 | 1.35 | ||||
Botella et al., 2007 | Agoraphobia | Completer = ITTc | FQ-Agoraphobia | VRET | 12 | 16.27 | 14.19 | 6.82 | 7.61 | 0.77 | −0.09 | 1.64 |
IVET | 12 | 14.58 | 11.80 | 4.25 | 6.35 | 1.01 | 0.07 | 1.95 | ||||
Meyerbroeker et al., 2013 | Agoraphobia | ITTb | ACQ | VRET | 24 | 2.58 | 0.52 | 1.96 | 0.53 | 1.14 | 0.43 | 1.85 |
IVET | 22 | 2.63 | 0.66 | 2.02 | 0.74 | 0.84 | 0.17 | 1.51 |
This table provides means and standard deviations of pre and post measurements on the stated anxiety measures, as well as pre to post effect sizes for VR exposure therapy (VRET) and in vivo exposure therapy (IVET) of all studies included in the meta-analysis. Effect sizes were reported as Hedges' g. The statistical values either refer to the completer sample (Completer) or to the intent-to-treat sample (ITT), as mentioned. Studies are sorted by the type of phobia and date of publication. AQ-Anxiety, Acrophobia Questionnaire, Anxiety-subscale; FSQ, Fear of Spiders Questionnaire; FFI, Fear of Flying Inventory; PRCS, Personal Report of Confidence as a Speaker; LSAS-SR, Liebowitz Social Anxiety Scale; FQ-Agoraphobia, Fear Questionnaire – Agoraphobia; ACQ, Agoraphobic Cognition Questionnaire; CI, confidence interval; LL, lower limit; UL, upper limit.
The report did not present sample sizes and/or a declaration of ITT or completer sample in the table on means and standard deviations, information from the text was used for specification.
Patients from waitlists were allocated to the VRET and IVET condition and included in the analysis.
The authors reported the same sample size for the number of participants included in the study and the analysis sample.